Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Shares Issued (2017 - 2024)

Puma Biotechnology (PBYI) has disclosed Shares Issued for 6 consecutive years, with $150000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Shares Issued changed N/A year-over-year to $150000.0, compared with a TTM value of $150000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $130000.0, down 13.33% over the prior year.
  • Shares Issued was $150000.0 for Q3 2024 at Puma Biotechnology, up from -$10.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $10.0 million in Q1 2022 and bottomed at -$10.0 million in Q4 2022.
  • Average Shares Issued over 3 years is $29600.0, with a median of $43000.0 recorded in 2020.
  • Peak annual rise in Shares Issued hit 43.42% in 2020, while the deepest fall reached 4400.0% in 2020.
  • Year by year, Shares Issued stood at -$45000.0 in 2020, then crashed by 22122.22% to -$10.0 million in 2022, then surged by 101.5% to $150000.0 in 2024.
  • Business Quant data shows Shares Issued for PBYI at $150000.0 in Q3 2024, -$10.0 million in Q4 2022, and $10.0 million in Q1 2022.